Information For Authors

Bariatric Surgical Practice and Patient Care (formerly Bariatric Nursing and Surgical Patient Care) publishes the cutting-edge research, clinical protocols, and practical tools to provide optimal care for bariatric surgical patients, whose health is seriously compromised by their high BMI and comorbid conditions.  Each issue will include original papers, clinical reviews, profiles of successful bariatric surgical programs, case reports letters to the editor, and much more. The Journal does not publish papers that have been submitted elsewhere.

LETTERS TO THE EDITOR(S):

Letters to the Editor(s) are welcomed, but with a 500-word limit and no more than one (1) table OR figure, and with a maximum of four (4) references.
 

Manuscripts must be submitted online using the following URLhttp://mc.manuscriptcentral.com/bari

Please read all the instructions to authors before submitting.

Follow all prompts on Manuscript Central for inputting all required manuscript details. Please upload all files pertaining to your paper individually; do NOT combine all manuscript files into one PDF for uploading. Manuscript Central prepares a PDF proof after uploading is completed

AUTHORSHIP

Authorship should be determined at the time of submission. Ensure the author listing is complete and all names are spelled correctly.  According to the International Committee of Medical Journal Editors (ICJME), authorship is based on the following criteria:

  1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  2. Drafting the work or revising it critically for important intellectual content; AND
  3. Final approval of the version to be published; AND
  4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Corresponding Author:  It is the Journal’s policy that a submission carries only ONE corresponding author.  This designation should be determined at the time of submission.  All communications, except for individual copyright forms, will be managed through the corresponding author.

 

Acknowledgment of Non-Qualifying Contributors

Contributors who do not meet all four (4) of the above criteria for authorship should not be listed as authors, but they may be recognized in an Acknowledgment section. Some examples of activities that alone (without other contributions) do not qualify for authorship are: 

 

  • Acquisition of funding;
  • General supervision of a research group or general administrative support;
  • Writing assistance, technical editing, language editing, and proofreading.

 

Those whose contributions do not justify authorship may be acknowledged individually or together as a group under the heading, Acknowledgments, and should be included in at the end of the manuscript before the Author Disclosure Statement(s).

 

Submitting Author/Agent:  It is incumbent upon the submitting author/agent to ensure the inclusion and accuracy of all contributing authors’ names, valid email addresses, and affiliations upon original submission of the paper. Once a paper is accepted for publication, changes in authorship are generally not permitted.  Changes in authorship after publication are strictly prohibited.

 

Keywords (Areas of Expertise)

To facilitate the peer review process, select 4-6 keywords from the drop-down list of pre-selected terms when submitting your manuscript.   These keywords will assist in the selection of skilled reviewers in the field for the purposes of peer review.

PREPARATION OF MANUSCRIPT

All manuscripts must be prepared in accordance with the "Uniform Requirements for Manuscripts Submitted for Biomedical Journals." Prepare manuscripts in Microsoft Word, double spaced on 8 1/2" by 11" pages. Leave ample margins on the sides, top, and bottom of pages. The order of items in the manuscript is: title page, abstract, text, acknowledgments, references, reprint address, legends, and tables. Each page, including the title page, must be numbered in the upper right-hand corner. Number pages consecutively.

Title Page. The title page should include the contributors’ names with highest academic degrees, affiliations, the source of a work or study (if any), and a running head of about 45 characters. Please also indicate on the title page the name, complete mailing address, phone number, fax number, and email addressof the author to whom correspondence should be addressed.   Manuscript keywords (search terms): On the title page of the manuscript, include a minimum of three (3), maximum of six (6), search terms that will aid in the discoverability of the article in indexing services and search engines.  These terms may or may not be different from the terms you selected for the peer review process and areas of expertise.  You will be asked to retype these search terms in the submission form when uploading your manuscript.  These keywords will be included in the published article.  If the search terms entered do not match the manuscript, the manuscript will serve as the default.



Abstract. The second page should consist of a structured abstract of no more than 200 words, which should be self-explanatory without reference to the text. It should be double spaced and should summarize the purpose of the study, the main findings, and the principal conclusions. Please note that references should not be cited in the abstract. Papers should contain original data concerning the course (prognosis), cause (etiology), diagnosis, treatment, prevention, or economic analysis of a clinical disorder or an intervention to improve the quality of healthcare.

Text. In general, the text (which must be double spaced) should be organized under the headings: Introduction, Materials and Methods, Results, Discussion, and Conclusions. Use only standard abbreviations, which can be found in the AMA’s Manual for Authors & Editors or the Council of Biology Editors Style Manual. At first usage, spell out terms and give abbreviations in parentheses. Thereafter, use only abbreviations. It is not necessary to spell out standard units of measure, even at first usage. Use generic names for drugs if possible. If you wish to use a proprietary drug name the first time it appears, use the generic name followed by the proprietary name, manufacturer, and city in parentheses.

Acknowledgments.

The author should acknowledge only those people and their institutions that have made significant contributions to the study.

References.

References must be typed double spaced and numbered consecutively as they are cited in the text (using superscript numbers). References appearing for the first time in tables and figures must be numbered in sequence with those cited in the text where the table or figure is mentioned. Use journal abbreviations as provided by MEDLINE, (The National Library of Medicine.)  List all authors when there are six or less. When there are more than six, list the first six, followed by et al. If references to personal communications or unpublished data are used, they are not to be in the list of references. They should be referred to in the text in parentheses: (F.P. Jones, personal communication, and date of correspondence.) Include any accepted papers but not yet published in the reference list; name the journal, and add "In Press" in parentheses.

Sample references are:

  • Journal paper:  Livingston EH.  Complications of bariatric surgery.  Surg Clin North Am 2005;84:853 – 868.
  • Book: Martin LF.  Obesity Surgery. McGraw Hill, 2004.
  • Edited book: Mitchell JE and de Zwaan M (eds.) Bariatric Surgery. Oxford, UK: Taylor & Francis, Inc., 2005.
  • Chapter in a book:  Flancbaum L. Complications of Weight Loss Surgery. In: Flacnbaum L, Flancbaum D. Manfred E. (eds.) The Doctor's Guide to Weight Loss Surgery. New York: Bantam Dell Books, 2003:78.

 

ETHICAL CONSIDERATIONS IN THE CONDUCT AND REPORTING OF RESEARCH:

PROTECTION OF HUMAN SUBJECTS AND ANIMALS IN RESEARCH


Patients and Study Participants


All manuscripts must comply with the privacy and confidentiality requirements outlined on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals website. For more information, visit  http://www.icmje.org/recommendations/browse/roles-and-responsibilities/protection-of-research-participants.html    

When articles include reports of studies on human subjects, state in the Methods section that an appropriate institutional review board or ethics committee approved the study. Authors who do not have formal ethics review committees should follow the principles of the Declaration of Helsinki. In the Methods section, state that informed consent was obtained from subjects (specify written or verbal).

 

The principal author must state that if animals were used experimentally, permission was obtained from the appropriate committee(s), and that the animals were treated humanely and the standards conformed to those of current ethical animal research practices.

 

In addition, text and photographs should not reveal any identifying information unless it is essential for scientific purposes (in which case, consent should be obtained). Masking the subjects’ eyes in photographs is often insufficient to protect their identity.

 

PUBLICATION ETHICS AND MALPRACTICE STATEMENT

 

Study Design and Ethics

Documented review and approval from a formally constituted review board (Institutional Review Board or Ethics committee) should be required for all studies involving people, medical records, and human tissues. For those investigators who do not have access to formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. If the study is judged exempt from review, a statement from the committee should be required. Informed consent by participants should always be secured. If not possible, an institutional review board must decide if this is ethically acceptable. This information should be outlined in the cover letter accompanying the submission, and a sentence declaring adherence should be included in the acknowledgment section of the manuscript.

Animal experiments should require full compliance with local, national, ethical, and regulatory principles, and local licensing arrangements.

Definitions of Scientific Misconduct

Mary Ann Liebert, Inc., publishers generally follows the guidelines and rules regarding scientific misconduct put forth by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Office of Research Integrity (ORI).

Scientific misconduct and violation of publishing ethics vary and can be intentionally or unintentionally perpetrated. Some examples of misconduct and violations include, but are not limited to, the following:

  • Scientific Misconduct: Fabrication, falsification, concealment, deceptive reporting, or misrepresentation of any data constitutes misconduct and/or fraud.

  •  Authorship Disputes: Deliberate misrepresentation of a scientist’s contribution to the published work, or purposefully omitting the contributions of a scientist.

  • Misappropriation of the ideas of others: Improper use of scholarly exchange and activity may constitute fraud. Wholesale appropriation of such material constitutes misconduct.

  • Violation of generally accepted research practices: Serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results constitutes misconduct and/or fraud.

  • Material failure to comply with legislative and regulatory requirements affecting research:
    Including but not limited to serious or substantial, repeated, willful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials constitutes misconduct.

  • Conflict of Interest:  Nondisclosure of any conflicts, direct or indirect, to the Journal which prevents you from being unbiased constitutes misconduct.

  • Deliberate misrepresentation: of qualifications, experience, or research accomplishments to advance the research program, to obtain external funding, or for other professional advancement constitutes misconduct and/or fraud.

  • Plagiarism: Purposely claiming another’s work or idea as your own constitutes misconduct and/or fraud.

  • Simultaneous Submission:  Submitting a paper to more than one publication at the same time constitutes misconduct.

Responding to Allegations of Possible Misconduct

The Publisher is committed to helping protect the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct an appropriate investigation into an allegation.  As such, all allegations of misconduct will be referred to the Editor-In-Chief of the Journal who in turn will review the circumstances, possibly in consultation with associate editors and/or members of the editorial board. Initial fact-finding will usually include a request to all the involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-In-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an editor, an outside expert. The Editor-In-Chief will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.

When allegations concern authors, the peer review and publication process for the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the authors withdraw their paper.  In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.

Editors or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal, and reported to their institution.

If an inquiry concludes there is a reasonable possibility of misconduct, the Editor-in-Chief will retract the paper from the Journal and the scientific record.  If the paper is still under peer review, the Editor-in-Chief will withdraw the paper from consideration to the Journal.

All allegations will be kept confidential.

Reprint Address.

Following the references, provide the name and complete address of the person to whom reprint requests should be sent.

Legends.

Each legend for illustrations must be double spaced on a separate page. In the legend, provide explanations for any abbreviations, arrows, etc. on the art work. If the illustration is taken from a copyrighted publication, permission must be obtained and the appropriate credit must be given in the legend.

Tables.

Prepare tables double spaced, each on a separate page, and provide a title for each table. Cite tables in sequence in the text. Explain abbreviations or symbols used in the body of the table in table footnotes. If the table is taken from a copyrighted publication, permission must be obtained and the appropriate credit must be given in the table footnote.

Illustrations.

Cite figures consecutively in the manuscript within parentheses: Example: “Before and after photos of the stomach in a Roux-en-Y procedure (Fig. 2A).” All illustrations should be clearly numbered and labeled with the first author's name on the front of the figure. A legend should be supplied for each figure or illustration, and all legends should be numbered consecutively and provided (double spaced) on a separate page. Figures should be numbered in the order cited in the text. Images should not show the name of any manufacturer.

Instructions for electronic submission of art:

  • Do not include any illustrations as part of your text file. Each figure should be in its own separate file, and should NOT be prepared as a Word file.
  • Line illustrations should be submitted at 600 DPI.
  • Halftones and color photos should be submitted at a minimum of 300 DPI.
  • Adobe is the preferred software.  Avoid submitting PowerPoint files.
  • Save art as either TIFF or EPS files.  Avoid submitting JPEG files.
  • Color art must be saved as CYMK, not RGB.
  • Provide a laser printout of all art to ensure accuracy.

 

PERMISSIONS

Materials taken from other sources must be accompanied by a written statement from both the author (if applicable) and publisher giving permission to (re)print in Bariatric Surgical Practice and Patient Care. Such clearance should be provided with the manuscript. Written permission must be obtained and submitted from authors to cite unpublished data or papers still in press.

REPRINTS

Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.

DISCLOSURE STATEMENT

Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.  In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal.  It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist."

 

PUBLISHER

The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740–2100; fax: (914) 740–2101; email: info@liebertpub.com

 

Our dynamic Author Benefits Program provides you with end-to-end benefits that ensure your hard work pays off and your published manuscript gets the attention it deserves not just upon publication, but permanently.

Liebert Open Access

Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option

Explore Liebert Open Access

Does your research funder have an open access mandate or would you like to expand the dissemination of your research?

The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.

The benefits of Liebert Open Access include:

  • High visibility; open access articles are freely available online upon publication
  • You retain copyright with the open access license allowing broad dissemination of your research
  • You can freely share your article in repositories and research networks without restrictions
  • Easy compliance with open access mandates
  • Rigorous editorial and peer-review
  • Targeted email announcement featuring a direct link to article

Identification and Marketing

Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.

Copyright and Licensing

If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.

Ordering Open Access

Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email openaccess@liebertpub.com.

Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form.  You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.

Publishing biomedical or biotechnology research?

Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.

 *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.

 

Valuable benefits of OA available for download.

Browse journals in the Liebert Open Access portfolio:

NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

Publishing in Subscription Journals

By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.

Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.

The final published article (version of record) can never be archived in a repository, preprint server, or research network.

 

Publishing Open Access

Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email openaccess@liebertpub.com or visit Liebert Open Access for more information.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.